Skip to Main Content

Paper Details

Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization.
JAMA Netw Open
8
2022
ASA, PAD, Participants, Patients, Peripheral Artery Disease, Rivaroxaban, VTE, Venous Thromboembolism, acetylsalicylic acid, aspirin, atherosclerotic vascular disease, clopidogrel, hypertension, men, obesity, patients, peripheral artery disease, rivaroxaban, venous and arterial thrombotic events, venous thromboembolism
Author NameAffiliation
Sonia S AnandPopulation Health Research Institute, McMaster University
Manesh R PatelDuke Clinical Research Institute, Duke University Medical Center
Joshua A BeckmanVanderbilt University Medical Center
  • 1 - 3

Datasets

Release 1.2